Major depressive disorder (MDD) is associated with the number of years lived with disability globally,
1 affecting approximately 5% to 6% of people worldwide each year and 11% to 15% of people for a lifetime.
2,3 The high burden of MDD exists, in part, because many people do not receive effective care.
4,5 Many studies have defined potentially effective care for MDD using objective criteria, usually in terms of the number of professional visits and either the type of professional seen or the type of intervention received. However, patient-centered definitions can also help to identify needs that are not fully met by treatment and in turn can inform policy and service responses to address these needs.
6-8 Thus, a patient’s evaluation of the helpfulness of treatment is an important measure
9,10 that can be collected directly and efficiently
11,12 and, when assessed in population surveys, can help fill a knowledge gap about treatment outcomes at a population level.
11